WHO ICTRP trial
Effects of zoledronic acid on glycated hemoglobin, glucose metabolism, islet…
ChiCTR2000033219 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000033219 |
|---|---|
| Public title | Effects of zoledronic acid on glycated hemoglobin, glucose metabolism, islet cell function, and the incidence of type 2 diabetes: a retrospective and prospective study |
| Scientific title | Effects of zoledronic acid on glycated hemoglobin, glucose metabolism, islet cell function, and the incidence of type 2 diabetes: a retrospective and prospective study |
| Primary sponsor | Department of Endocrinology, Affiliated Hospital of Southwest Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | Osteoporosis, diabetes |
| Interventions | Diabetes mellitus with osteoporosis group:Zoledronic acid;Diabetes mellitus group:Zoledronic acid |
| Registration date | May 24, 2020 |
| Target size | Diabetes mellitus with osteoporosis group:30;Diabetes mellitus group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: